Vicarious Surgical Inc. hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting presentations by representatives from leading healthcare provider University Hospitals and renowned surgeon Dr. Igor Belyansky outlined the extensive opportunity for Vicarious to address current shortcomings in surgical robotics at the system and user level. As part of the Beta 2 Demonstration Day event, Dr. Belyansky reviewed intra-operative video of his recent cadaveric ventral hernia repair procedures in which he utilized the Vicarious Surgical Beta 2 system.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3814 USD | -9.69% | +33.82% | +4.01% |
Apr. 29 | Transcript : Vicarious Surgical Inc., Q1 2024 Earnings Call, Apr 29, 2024 | |
Apr. 29 | Vicarious Surgical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.01% | 56.15M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.27% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- RBOT Stock
- News Vicarious Surgical Inc.
- Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System